SOURCE: Sancilio & Company

November 10, 2008 16:02 ET

Sancilio & Company Announces the Appointment of Dr. Rizwan Kazmi as Senior Director of Pharmaceutical Research and Development

RIVIERA BEACH, FL--(Marketwire - November 10, 2008) - Sancilio & Company, Inc., headquartered in Riviera Beach, Florida, is pleased to announce the appointment of Dr. Rizwan Kazmi as Senior Director of Pharmaceutical Research and Development.

Dr. Kazmi brings to Sancilio & Company, Inc., over 30 years of formulation development and manufacturing experience as well as a vast knowledge of pharmaceutical sciences. He has extensive knowledge in Branded and Generic product development and an understanding of cGMP, Regulatory and Quality Assurance. During his professional career, Dr. Kazmi has developed more than 200 pharmaceutical products.

For seven and a half years, before joining Sancilio & Company, Inc., Dr. Kazmi was employed with Pharmaceutical International, Inc. (Pii) in Baltimore. Prior to that, he worked for Patheon Inc. (Canada) as a Senior Scientist in Formulation Development.

Dr. Kazmi has held key management and research and development positions with several multi-national pharmaceutical companies, including Bayer-Pharma, Roche, Eli Lilly, Boehringer Mannheim, Asta Medica, and Ali Gohar pharmaceutical.

Dr. Kazmi received his Bachelor's and Master's degrees in Pharmacy and his D.Sc. and PhD. in Pharmaceutical Technology and has published several articles in various professional publications.

About Sancilio & Company, Inc.

SCI was founded by Dr. Frederick D. Sancilio, a recognized leader in pharmaceutical research and development for over 30 years. The company operates US FDA registered laboratories in Riviera Beach, Florida and has recently begun offering contract manufacturing services to global pharmaceutical and nutritional companies seeking high quality production of their products.

Operating out of 18,000 square feet of newly completed facilities, SCI produces and packages sophisticated formulations of tablets and capsules into bottles or blister packages.

SCI maintains registration with the US FDA, US DEA and complies with state and federal laws pertaining to the products manufactured and distributed. In addition to its corporate office in Florida, SCI maintains offices in New Jersey servicing the east coast and Colorado that services the west coast of the United States.

To obtain more information or schedule an interview, please contact Gail Isaacs, Public Relations Coordinator at or 561.847.2302, ext. 117. Please visit our website at

Contact Information